Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.
NeuroRehabilitation·2014
Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy.
Multiple sclerosis (Houndmills, Basingstoke, England)·2002
Surgery for spinal cord compression in multiple sclerosis.
Current opinion in neurology·2001
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Archives of neurology·2001
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice.
Journal of immunology (Baltimore, Md. : 1950)·2001
Unfractionated Heparin and Low-Molecular-Weight Heparin in Sepsis: Anti-Inflammatory and Anticoagulant Effects Versus No Anticoagulation-A Propensity Score-Matched Analysis.
Journal of clinical laboratory analysis·2026
The ubiquitin system in normal and infected germinal center B cells.
FEBS letters·2026
Gut Microbiota Mediates the Relationship Between Immune Cells and Familial Hypercholesterolemia: A Mendelian Randomization Study.
Endocrine, metabolic & immune disorders drug targets·2026
Tumor-responsive nanoparticles precisely overcome hypoxia-mediated STING dysfunction to unleash potent antitumor immunity.
Acta pharmaceutica Sinica. B·2026
Self-assembled supramolecular nanoparticles of α-mangostin for targeted STING activation and enhanced tumor immunotherapy.
Acta pharmaceutica Sinica. B·2026